Showing 3111-3120 of 4169 results for "".
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- Congrats! Lisa M. Donofrio, MD Named New ASDS/ASDSA Presidenthttps://modernaesthetics.com/news/congrats-lisa-m-donofrio-md-named-new-asdsasdsapresident/2472179/Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers and the ASDS / ASDSA
- Cutera's truSculpt May Help Reduce Fat in the Lower Facehttps://modernaesthetics.com/news/cuteras-trusculpt-may-help-reduce-fat-in-the-lower-face/2472193/Static type monopolar 1-MHz radiofrequency may help reduce fat and tighten skin in the lower face, according to research published in Lasers in Surgery and Medicine. “We objectively observed a volumetri
- Allergan CEO Calls for Consensus on Medical Aesthetic Treatment in Minorshttps://modernaesthetics.com/news/allergan-ceo-calls-for-consensus-on-medical-aesthetic-treatment-in-minors/2472213/Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a new blog post, he writes “we must remember that anyone under the age of 18 is still matu
- Alma Lasers Inc. Hair Removal Platform Now Comprises Three Wavelengthshttps://modernaesthetics.com/news/alma-lasers-inc-hair-removal-platform-now-comprises-three-wavelengths/2472221/Alma Lasers now offers 1064 Nd: YAG capabilities along with 810nm and 755nm on its Soprano ICE platform, allowing users to better match wavelength to hair removal patient. Alma added Alexandrite technology to its Soprano ICE platform in 2014 for
- New AAFPRS Data: More Than 30 Percent of Men Are Considering Nips and Tuckshttps://modernaesthetics.com/news/new-aafprs-data-more-than-30-percent-of-men-are-considering-nips-and-tucks/2472223/The plastic surgery ‘menaissaince’ may really be a thing, finds a new survey from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). It turns out that 31 percent of men said they are “extremely likely&rdq
- Nearly 10.5 Million Treatments Performed by ASDS Members in 2016https://modernaesthetics.com/news/nearly-105-million-treatments-performed-by-asds-members-in-2016/2472226/Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016 – five percent more than 2015 and up 31 percent since 2012, according to the 2016 American Society for Dermatologic Surgery (ASDS) Survey on D
- ThermiGen, an Almirall company, Names Vladimir Paul-Blanc President & General Managerhttps://modernaesthetics.com/news/thermigen-an-almirall-company-names-vladimir-paul-blanc-president-general-manager/2472245/Vladimir Paul-Blanc has been named President & General Manager of ThermiGen, LLC, starting May 1. He will report directly to the Executive Vice-president of Commercial Strategy of Almirall, Alfonso Ugarte, and he will be responsible for all general management responsibilities for the Thermi b
- ASAPS 2016: Labiaplasty More Than A Fadhttps://modernaesthetics.com/news/asaps-2016-labiaplasty-more-than-a-fad/2472263/When it rains, it pours. Both the American Society of Plastic Surgeons (ASPS) and sister organization American Society for Aesthetic Plastic Surgery (ASAPS) released some (ASAPS) or all (ASPS) of their annual statistics. And by and
- Cynosure to Be Acquired by Hologichttps://modernaesthetics.com/news/cynosure-to-be-acquired-by-hologic/2472278/Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion